-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
1.
1.
This means that on the eve of Children's Day this year, we ushered in a blockbuster Children's Day gift-the three-child birth policy is officially here.
What does the three-child policy mean to the pharmaceutical industry? There is no doubt that it is a strong market demand.
Let’s take the previous two-child policy as an example.
According to data from the National Bureau of Statistics, in 2019, despite the slight decline in the national fertility level, in terms of the number of births, the proportion of the second child and above in the birth population was significantly higher than that of the first child.
With the opening of the two-child policy, the children's drug market has also ushered in explosive growth.
2011-2018 China's children's drug industry market size statistics and growth
(Data source: Qianzhan Industry Research Institute)
In terms of market performance, children's drug manufacturers have also ushered in a wave of performance growth after the opening of the two-child policy.
Taking Kangzhi Pharmaceutical as an example, revenue in 2018 and 2019 achieved growth of 32.
With the implementation of my country's three-child birth policy, the number of newborns has increased, which means that my country's children's medicine market will further expand.
2.
2.
In terms of manufacturing companies, according to a survey by the National Federation of Industry and Commerce Pharmaceutical Chambers, as of September 2019, among the more than 6000 pharmaceutical factories in my country, only more than 10 specialize in the production of children's drugs, and only more than 30 companies have a children's drug production department.
According to the analysis of the Prospective Industry Research Institute, as a special group of medicine consumption, the types of children's medicines in my country account for less than 10% of the total medicines, and more than 90% of children's medicines in China are non-child-specific medicines.
Percentage of domestic children's drugs in 2020
(Data source: Qianzhan Industry Research Institute)
According to Insight database statistics, as of January 1, 2021, my country has included 228,448 approved products (chemical drugs, traditional Chinese medicines, and biological preparations, etc.
Domestic pediatric-specific products have a small number of approval documents and active ingredients.
